Future Market Insights delivers key insights on the global renal
biomarker market in a new report titled “Renal Biomarker Market:
Global Industry Analysis and Opportunity Assessment, 2016–2026.”
In terms of revenue, the global renal biomarker market is projected
to register a healthy CAGR of 7.0% over the forecast period. In this
report, Future Market Insights throws light on the various factors
and trends impacting market growth over the forecast period (2016 –
2026).
Read Report Overview @
https://www.futuremarketinsights.com/reports/renal-biomarker-market
The global renal biomarker market is segmented on the basis of
Biomarker Type (Functional Biomarker, Up-Regulated Proteins, Others);
Diagnostic Technique (Enzyme Linked Immunosorbent Assay,
Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay,
Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass
Spectrometry); and End User (Diagnostic Labs,Outpatient Clinics,
Research Centres, Hospitals).
The Functional Biomarker type segment is anticipated to be valued at
US$ 471.2 Mn by the end of 2016, registering a CAGR of 7.6% over the
forecast period. The Up-Regulated Proteins type segment is estimated
to create absolute $ opportunity of US$ 19.5 Mn in 2017 over 2016
The Enzyme Linked Immunosorbent Assay diagnostic technique segment is
anticipated to witness high Y-o-Y rates of growth throughout the
forecast period and is anticipated to reach a market valuation of US$
390.9 Mn by the end of 2016. The Particle-Enhanced Turbidimetric
Immunoassay diagnostic technique segment is estimated to register a
CAGR of 7.0% over the forecast period
Request Sample Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1731
The Diagnostic Labs end user segment is anticipated to reach a market
value share of US$ 308.4 Mn by the end of 2016. The Outpatient
Clinics end user segment is estimated to hold a market value share of
30.1% by the end of 2016, making it the second highest end user
growth segment of the global renal biomarker market
The global renal biomarker market is segmented into the seven key
regions of North America, Latin America, Western Europe, Eastern
Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East &
Africa (MEA). The North America renal biomarker market is projected
to witness high Yea-on-Year growth throughout the forecast period.
The market in this region is anticipated to witness a CAGR of 7.6%
over the forecast period. The presence of leading renal biomarker
manufacturers and established distribution channels in North America
is expected to create significant growth opportunities over the next
10 years. The Western Europe renal biomarker market is estimated to
represent absolute $ opportunity of US$ 14.1 Mn in 2017 over 2016.
The global renal biomarker market report profiles a few of the top
companies dominating the global market. Leading market players
featured in the report include Thermo Fisher Scientific Inc.,
BIOPORTO A/S, Abbott Laboratories, Astute Medical, Inc., Randox
Laboratories Ltd. and Beckman Coulter, Inc. (Danaher Corporation).
The report discusses individual strategies adopted by these companies
in terms of enhancing product designing, creating new manufacturing
facilities, market consolidation, and advanced R&D initiatives.
Buy Full Renal Biomarker Market Report @
https://www.futuremarketinsights.com/checkout/1731
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email:
sales@futuremarketinsights.com
Website:
www.futuremarketinsights.com
No comments:
Post a Comment